From AI overreliance to fragmented data and poor collaboration, internal issues are quietly undermining SEO performance. Here ...

Learn expert tips on preparing for the conversation, explaining disease progression, and discussing legal and financial plans to ensure that your wishes are met.

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a ...